| 日期 | 股東名稱 | 披露原因 | 買入/賣出涉及 的股份數目 |
每股平均價 | 持有權益的 股份數目 |
佔已發行 股本(%) |
| 12/11/2026 | China Pharmaceutical Company Limited | 1710(L) | +500,000(L) | HKD2.614(L) | 930,504,000(L) | 31.53 |
| 12/11/2026 | 曲繼廣 | 1113(L) | +500,000(L) | HKD2.614(L) | 1,287,942,000(L) | 43.64 |
| 10/11/2026 | China Pharmaceutical Company Limited | 1710(L) | +1,100,000(L) | HKD2.660(L) | 930,004,000(L) | 31.51 |
| 10/11/2026 | 曲繼廣 | 1113(L) | +1,100,000(L) | HKD2.660(L) | 1,287,442,000(L) | 43.62 |
| 06/11/2026 | China Pharmaceutical Company Limited | 1710(L) | +1,000,000(L) | HKD2.649(L) | 928,904,000(L) | 31.47 |
| 06/11/2026 | 曲繼廣 | 1113(L) | +1,000,000(L) | HKD2.649(L) | 1,286,342,000(L) | 43.58 |
| 04/11/2026 | UBS Group AG | 1704(L) | -863,108(L) | HKD2.567(L) | 146,861,818(L) | 4.98 |
| 03/11/2026 | UBS Group AG | 1314(L) | 962,000(L) | 147,663,818(L) | 5.00 | |
| 02/11/2026 | UBS Group AG | 1314(L) | 1,639,688(L) | 150,022,692(L) | 5.08 | |
| 29/10/2026 | 曲繼廣 | 1113(L) | +1,500,000(L) | HKD2.607(L) | 1,285,342,000(L) | 43.55 |
| 29/10/2026 | China Pharmaceutical Company Limited | 1710(L) | +1,500,000(L) | HKD2.607(L) | 927,904,000(L) | 31.44 |
| 27/10/2026 | China Pharmaceutical Company Limited | 1710(L) | +1,200,000(L) | HKD2.610(L) | 926,404,000(L) | 31.39 |
| 27/10/2026 | 曲繼廣 | 1113(L) | +1,200,000(L) | HKD2.610(L) | 1,283,842,000(L) | 43.50 |
| 27/10/2026 | UBS Group AG | 1314(L) | 200,000(L) | 159,139,731(L) | 5.39 | |
| 02/10/2026 | 曲繼廣 | 1113(L) | +500,000(L) | HKD2.770(L) | 1,282,642,000(L) | 43.46 |
| 02/10/2026 | China Pharmaceutical Company Limited | 1710(L) | +500,000(L) | HKD2.770(L) | 925,204,000(L) | 31.35 |
| 29/09/2026 | China Pharmaceutical Company Limited | 1710(L) | +1,500,000(L) | HKD2.781(L) | 924,704,000(L) | 31.33 |
| 29/09/2026 | 曲繼廣 | 1113(L) | +1,500,000(L) | HKD2.781(L) | 1,282,142,000(L) | 43.44 |
| 28/09/2026 | 蘇學軍 | 1706(L) | 24,416,000(L) | 24,416,000(L) | 0.83 | |
| 25/09/2026 | China Pharmaceutical Company Limited | 1710(L) | +500,000(L) | HKD2.770(L) | 923,204,000(L) | 31.28 |
| 25/09/2026 | 曲繼廣 | 1113(L) | +500,000(L) | HKD2.770(L) | 1,280,642,000(L) | 43.39 |
| 24/09/2026 | 曲繼廣 | 1113(L) | +700,000(L) | HKD2.793(L) | 1,280,142,000(L) | 43.37 |
| 23/09/2026 | China Pharmaceutical Company Limited | 1710(L) | +1,250,000(L) | HKD2.797(L) | 922,704,000(L) | 31.26 |
| 23/09/2026 | 曲繼廣 | 1113(L) | +1,250,000(L) | HKD2.797(L) | 1,279,442,000(L) | 43.35 |
| 22/09/2026 | 曲繼廣 | 1113(L) | +1,000,000(L) | HKD2.762(L) | 1,278,192,000(L) | 43.31 |
| 21/09/2026 | 曲繼廣 | 1113(L) | +800,000(L) | HKD2.750(L) | 1,277,192,000(L) | 43.27 |
| 18/09/2026 | China Pharmaceutical Company Limited | 1710(L) | +1,150,000(L) | HKD2.734(L) | 921,454,000(L) | 31.22 |
| 18/09/2026 | 曲繼廣 | 1113(L) | +1,150,000(L) | HKD2.734(L) | 1,276,392,000(L) | 43.25 |
| 17/09/2026 | 曲繼廣 | 1113(L) | +1,400,000(L) | HKD2.768(L) | 1,275,242,000(L) | 43.21 |
| 17/09/2026 | China Pharmaceutical Company Limited | 1710(L) | +1,400,000(L) | HKD2.768(L) | 920,304,000(L) | 31.18 |
| 16/09/2026 | 曲繼廣 | 1113(L) | +850,000(L) | HKD2.711(L) | 1,273,842,000(L) | 43.16 |
| 15/09/2026 | 曲繼廣 | 1113(L) | +1,400,000(L) | HKD2.694(L) | 1,272,992,000(L) | 43.13 |
| 15/09/2026 | UBS Group AG | 1502(S) | -577,491(S) | 164,967,814(L) 29,039,167(S) | 5.59 0.98 | |
| 15/09/2026 | China Pharmaceutical Company Limited | 1710(L) | +1,400,000(L) | HKD2.694(L) | 918,904,000(L) | 31.13 |
| 14/09/2026 | 曲繼廣 | 1113(L) | +3,200,000(L) | HKD2.616(L) | 1,271,592,000(L) | 43.08 |
| 11/09/2026 | 曲繼廣 | 1113(L) | +1,000,000(L) | HKD2.621(L) | 1,268,392,000(L) | 42.98 |
| 11/09/2026 | China Pharmaceutical Company Limited | 1710(L) | +1,000,000(L) | HKD2.621(L) | 917,504,000(L) | 31.09 |
| 10/09/2026 | 曲繼廣 | 1113(L) | +870,000(L) | HKD2.623(L) | 1,267,392,000(L) | 42.94 |
| 10/09/2026 | China Pharmaceutical Company Limited | 1710(L) | +870,000(L) | HKD2.623(L) | 916,504,000(L) | 31.05 |
| 09/09/2026 | 曲繼廣 | 1113(L) | +880,000(L) | HKD2.731(L) | 1,266,522,000(L) | 42.91 |
| 1 2 3 4 5 | ||||||
| 備註: | (L) - 長倉:包括 (1) 持有股份;(2) 透過持有、沽出或發行金融合約,有權或有責任購買相關股份。 |
| (S) - 短倉:包括 (1) 借入股份;(2) 透過持有、沽出或發行金融合約,有權或有責任沽出相關股份。 | |
| (P) - 可供借出的股份 | |
| 即時報價更新時間為 13/11/2026 17:59 | |
| 港股即時基本市場行情由香港交易所提供; 香港交易所指定免費發放即時基本市場行情的網站 | |
新聞
股票
期貨期權N
權證
ETF
美股
A股
外匯黃金
加密貨幣
基金
MPF